Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A single-center, randomized, open-label, crossover study to evaluate the pharmacokinetic drug-drug interaction and safety of the quadruple therapy with Anaprazole 20mg/Amoxicilin 1000mg/Clarithromycin 500mg/Bismuth Potassium Citrate 0.6g in healthy Chinese male subjects.
Epistemonikos ID: 6ef60db4f3282abe696477dc9dba9694cd8f9d5f
First added on: May 07, 2024